The U.S. Agency for International Development and Becton, Dickinson and Company announced on Tuesday that they will collaborate to improve Indonesia's national reference laboratory systems and support the National Tuberculosis Program.
The new partnership will work to improve and expand early detection of TB, in addition to monitoring and administering treatment.
The collaboration is based on the President's Emergency Plan for AIDS Relief and BD's Labs for Life program. USAID and BD seek to integrate improved lab practices in 19 national labs supported by the NTP. They will also train workers on TB culture drug susceptibility testing and develop a nationally recognized accreditation and certification system.
"The United States partners with the Government of Indonesia, local governments, civil society, and the private sector to harness the power of scientific advances, accurate diagnostic tools, and world-class medical standards to stop and treat TB infections," U.S. Embassy Deputy Chief of Mission Kristen Bauer said. "We are committed to combating TB in Indonesia to save lives and avert tens of thousands of additional TB cases."
Independently, USAID and BD work to lower infectious disease and mortality in Indonesia. The country has a high rate of TB, ranking fourth for TB and eighth for multi-drug resistanct TB. Approximately 64,000 people die annually from TB in Indonesia.
"BD applauds USAID and the Ministry of Health in Indonesia for their leadership in the fight against TB," BD President of Greater Asia James Lim said. "BD is committed to accurately diagnosing TB and strengthening laboratories by training local healthcare workers on TB culture drug susceptibility testing."